Therapeutic Effect of a Novel Chimeric Molecule Targeting Both Somatostatin and Dopamine Receptors on Growth Hormone-Secreting Pituitary Adenomas

BACKGROUND: Acromegaly is a rare disease primarily caused by growth hormone (GH)-secreting pituitary adenomas, and its treatment is costly. Moreover, some patients are unresponsive to treatment. Hence, there are increasing efforts to develop new drugs with improved effectiveness for this disease. BI...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jean, Oh, Ju Hun, Harlem, Heather, Culler, Michael D., Ku, Cheol Ryong, Lee, Eun Jig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090307/
https://www.ncbi.nlm.nih.gov/pubmed/32207278
http://dx.doi.org/10.3803/EnM.2020.35.1.177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090307/
https://www.ncbi.nlm.nih.gov/pubmed/32207278
http://dx.doi.org/10.3803/EnM.2020.35.1.177

Ejemplares similares